Tuberculosis and Respiratory Diseases

Scope & Guideline

Exploring the frontiers of respiratory disease management.

Introduction

Welcome to your portal for understanding Tuberculosis and Respiratory Diseases, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1738-3536
PublisherTHE KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASES
Support Open AccessYes
CountrySouth Korea
TypeJournal
Convergefrom 1980 to 2024
AbbreviationTUBERC RESPIR DIS / TUBERC. RESP. DIS.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address101-605, 58, Banpo-daero, Seocho-gu, SEOUL 06652, SOUTH KOREA

Aims and Scopes

The journal 'Tuberculosis and Respiratory Diseases' primarily focuses on advancing research and knowledge surrounding respiratory diseases, particularly tuberculosis and chronic obstructive pulmonary disease (COPD). It aims to publish high-quality research that enhances the understanding, diagnosis, treatment, and management of these conditions.
  1. Tuberculosis Research:
    The journal emphasizes studies related to tuberculosis, including epidemiology, treatment strategies, and the development of novel diagnostic methods, aiming to improve patient outcomes and public health responses.
  2. Chronic Obstructive Pulmonary Disease (COPD):
    Research on COPD is a core focus, covering various aspects such as pathophysiology, management strategies, exacerbation definitions, and the impact of comorbidities on patient health.
  3. Lung Cancer and Respiratory Neoplasms:
    The journal includes significant research on lung cancers, particularly non-small cell lung cancer, exploring treatment advancements, biomarkers for prognosis, and patient management.
  4. Infectious Respiratory Diseases:
    In addition to tuberculosis, the journal addresses other infectious respiratory diseases, including studies on viral infections like COVID-19, their clinical outcomes, and the impact on patients with pre-existing respiratory conditions.
  5. Pulmonary Rehabilitation and Patient Quality of Life:
    The journal publishes research on rehabilitation programs and interventions aimed at improving the quality of life for patients with chronic respiratory diseases, integrating psychological and social aspects.
  6. Environmental and Lifestyle Factors:
    Research on the effects of environmental factors, such as air pollution and smoking, on respiratory health is highlighted, recognizing their role in exacerbating conditions like COPD and asthma.
The journal has been actively adapting to new challenges and innovations in the field of respiratory diseases, leading to emerging themes that are gaining prominence. This section outlines these trending areas of focus.
  1. Impact of Digital Health Technologies:
    Recent publications highlight the integration of digital health solutions, such as telemedicine and mobile health applications, to improve medication adherence and patient management in respiratory diseases.
  2. Long-COVID and Post-Acute Sequelae:
    Research exploring the long-term effects of COVID-19 on respiratory health, including complications and management strategies, is increasingly significant, reflecting ongoing concerns about the pandemic's impact.
  3. Biomarkers and Personalized Medicine:
    There is a growing interest in identifying biomarkers for predicting disease progression and treatment response in tuberculosis and lung cancer, paving the way for personalized treatment approaches.
  4. Rehabilitation and Quality of Life Initiatives:
    Studies focusing on the rehabilitation of patients with chronic respiratory diseases and their quality of life are on the rise, emphasizing the holistic management of these conditions.
  5. Environmental Health and Respiratory Disease Interactions:
    Research on the interplay between environmental factors, such as air pollution, and respiratory diseases is becoming more prevalent, underscoring public health implications.

Declining or Waning

While certain themes remain prominent, others are showing signs of declining interest or fewer publications in recent years. This section identifies those waning scopes within the journal's focus.
  1. Traditional Tuberculosis Epidemiology Studies:
    There appears to be a shift away from basic epidemiological studies of tuberculosis towards more innovative research focusing on treatment and management strategies, as well as integration of technology.
  2. General Asthma Research:
    While asthma remains a topic of interest, the publication of studies focused solely on asthma without connections to COPD or other comorbidities is decreasing, indicating a trend towards integrated respiratory disease research.
  3. Historical Perspectives on Respiratory Diseases:
    Research that primarily revisits historical data or long-standing paradigms without introducing new insights or advancements is less frequently published, suggesting a preference for contemporary and innovative research.
  4. Pharmacological Studies on Older Medications:
    There is a noticeable decline in research focused on older medications for respiratory diseases, as the journal increasingly prioritizes studies on newer therapeutic options and combination therapies.

Similar Journals

EUROPEAN RESPIRATORY JOURNAL

Shaping the Future of Respiratory Care
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0903-1936Frequency: 12 issues/year

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

Minerva Respiratory Medicine

Pioneering insights for a healthier breath.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2784-8477Frequency: 4 issues/year

Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.

Zeitschrift fur Pneumologie

Empowering Knowledge for Better Respiratory Care
Publisher: SPRINGER HEIDELBERGISSN: 2731-7404Frequency: 6 issues/year

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.

LUNG

Elevating respiratory medicine through rigorous research.
Publisher: SPRINGERISSN: 0341-2040Frequency: 6 issues/year

LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.

THORAX

Navigating the complexities of pulmonary medicine.
Publisher: BMJ PUBLISHING GROUPISSN: 0040-6376Frequency: 12 issues/year

THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.

Breathe

Exploring new horizons in lung health.
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 1810-6838Frequency: 4 issues/year

Breathe, published by the European Respiratory Society Journals Ltd, is a prominent open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. With an ISSN of 1810-6838 and an E-ISSN of 2073-4735, this journal has been contributing to scholarly discourse since 2008. Nestled in the United Kingdom, it serves as a vital platform for researchers, clinicians, and educators, particularly in the areas of respiratory pathophysiology, diagnostic methods, and therapeutic interventions. Currently classified in the third quartile (Q3) for pulmonary and respiratory medicine, Breathe ranks 91st out of 155 in Scopus, reflecting its growing influence in the discipline. The journal aims to publish high-quality, peer-reviewed research that fosters collaboration and innovation in lung health, making significant strides toward improving patient outcomes. Whether you are a seasoned professional or an up-and-coming researcher, Breathe offers a wealth of knowledge and resources to support your work in this crucial area of medicine.

Egyptian Journal of Bronchology

Advancing respiratory health through open access research.
Publisher: SPRINGERISSN: 1687-8426Frequency: 4 issues/year

Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.

Jornal Brasileiro de Pneumologia

Advancing respiratory health through innovative research.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

Thoracic Research and Practice

Empowering Respiratory Medicine with Open Access Insights
Publisher: AVESISSN: Frequency: 6 issues/year

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.

Respiratory Medicine and Research

Elevating standards in respiratory medicine.
Publisher: ELSEVIERISSN: Frequency: 2 issues/year

Respiratory Medicine and Research, published by Elsevier, is a pivotal journal in the field of Pulmonary and Respiratory Medicine, dedicated to advancing the understanding and treatment of respiratory diseases. Since its inception in 2019, the journal has provided a platform for high-quality research, contributing significantly to the scientific community's knowledge base, as reflected in its impressive Q2 categorization in 2023. With a Scopus rank of #94 out of 155, placing it in the 39th percentile, this journal is essential for researchers, professionals, and students seeking the latest advancements in respiratory medicine. Although currently categorized as a non-open access publication, it remains accessible to those affiliated with institutions with subscriptions. Published in France, the journal aims to foster collaboration and innovation by highlighting original research, clinical studies, and comprehensive reviews that address pressing issues in respiratory health.